Product
Ad5-triCoV/Mac
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Phase 1, Open Label Study to Evaluate the Safety and Immunogenicity of ChAd68 and AdHu5 Vector-based Trivalent COVID-19 Vaccines Delivered Via Inhaled AerosolStatus: Active (not recruiting), Estimated PCD: 2024-09-30